📰 Allo News
Page 11 - Allo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Allo. Real-time updates on events, politics, business and more.
April 8, 2023
Allogene Therapeutics (NASDAQ:ALLO – Get Rating) had its price objective lowered by HC Wainwright from $29.00 to $23.00 in a research note published on Tuesday morning, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Allogene Therapeutics’ Q1 2023 earnings at ($0.61) EPS, Q2 2023 […]
April 7, 2023
Elementary school. i was the same age as the thre children shot and murdered i other school in nashville, the shooting that provoked wha happened tonight in tennessee. that is what this histor making scene in tennessee an the legislature was all about. it was about the life and deat of children in america it was about those dea children and who was trying to protect the children i tennessee and who isnt. when you are in the middle o living history like this, yo owe it to yourself to stop wha you...
April 7, 2023
Connacht crashed out of this seasons European Challenge Cup despite high hopes of success when Italian outfit Benetton delivered a comprehensive 41-19 victory to advance to the quarter-finals.
April 6, 2023
Depp's first film since 2020, Jeanne du Barry, opens the festival in May. But will his old Hollywood friends be cheering him on?
April 4, 2023
Luis Arraez has been the Miami Marlins feel-good story this year.
April 4, 2023
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating)’s stock price reached a new 52-week low during mid-day trading on Tuesday after HC Wainwright lowered their price target on the stock from $29.00 to $23.00. The company traded as low as $4.81 and last traded at $4.82, with a volume of 412054 shares changing hands. The stock […]
March 28, 2023
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $4.91 and last traded at $4.92, with a volume of 840064 shares traded. The stock had previously closed at $5.03. Wall Street Analyst Weigh In A number of equities research […]
March 25, 2023
Sanford C. Bernstein assumed coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Get Rating) in a research note issued to investors on Tuesday morning, The Fly reports. The brokerage issued a market perform rating and a $6.00 target price on the stock. Several other brokerages also recently commented on ALLO. Truist Financial cut their target […]
March 25, 2023
Allogene Therapeutics (NASDAQ:ALLO – Get Rating)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Wednesday, PriceTargets.com reports. Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. upgraded Allogene Therapeutics from a “neutral” rating to an “overweight” rating and reduced their […]
March 21, 2023
The Arguss review of Peter Jamess Wish You Were Dead at the Theatre Royal Brighton.